AbbVie Inc's Fiscal Year is From January To December - All Figures are in Percent.
The item "Net-Buyback-Yield" stands at 0.4012 percent as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of AbbVie Inc's third quarter, the item "Net Buyback Yield" stands at 0.4012 Percent. This represents a decrease of -0.07 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.154 percentage points compared to the value the year prior.
The 1 year change in percentage points is -0.154.
The 3 year change in percentage points is -0.5814.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Net Buyback Yield | 905,699,262,464.00 |
![]() | Johnson & Johnson - Net Buyback Yield | 486,508,953,600.00 |
![]() | Roche Holding AG - Net Buyback Yield | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Net Buyback Yield | 280,205,508,085.11 |
![]() | Novartis AG - Net Buyback Yield | 255,096,620,580.91 |